A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

NCT01754844 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: AZD7624
DRUG: Placebo to match

Sponsor

AstraZeneca